Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · Praxis

Praxis Small Cap Index Fund Praxis Small Cap Index Fund Class A (MMSCX)

Ticker MMSCX · Index fund · · Holdings as of Jun 30, 2026

Expense ratio
0.94%$94/yr per $10k
5-yr return
+4.9%annualized
1-yr return
+0.6%as of Dec 2025
Net assets
$234.4Mall share classes
Holdings
717

Bottom line

Is MMSCX a good fund? The bottom line

MMSCX is a share class of Praxis Small Cap Index Fund, an index small-cap mutual fund from Praxis.

Its expense ratio is 0.94% — about $94 a year on every $10,000 invested, cheaper than 57% of small-cap funds we track.

It returned +0.6% over one year, +4.9% a year over five years, +6.4% a year over ten (as of Dec 31, 2025, per its prospectus).

With $234 million in net assets and 717 holdings, its largest position is N/a (19.2%) and the top 10 make up 23.4% of the portfolio.

This share class carries a front-end sales charge of up to 5.25%; a no-load class or ETF alternative can avoid it.

What stands out

  • Broadly diversified (717 holdings)

What to watch

  • Front-end sales load up to 5.25%
  • 12b-1 marketing fee of 0.25% a year

Updated Nov 19, 2026

What MMSCX invests in

The Praxis Small Cap Index Fund seeks to maximize long-term capital appreciation.

The Fund invests primarily in U.S. equity securities and seeks to reflect the performance of the U.S. small capitalization equities market, as measured by the CRSP U.S. Small Cap Index, its benchmark index. Under normal circumstances, the Fund invests at least 80 percent of the value of its assets in securities of, and investments related to, issuers in the Funds benchmark index. Typically, the Fund invests substantially more than 80 percent of the value of its assets in securities of issuers in its benchmark index. The Fund seeks to invest in companies aligned with the Praxis Stewardship Investing core values The Adviser does this by applying proprietary screens that reflect the Praxis Stewardship Investing core values. In addition, the Adviser uses optimization techniques to select securities according to their contribution to the Funds overall objective, while seeking to replicate…

From the fund's prospectus (filed Apr 20, 2026).

MMSCX performance

Fund calendar-year total returns, 2016–2025 2016: +8.2%; 2017: +10.7%; 2018: −8.6%; 2019: +21.4%; 2020: +10.4%; 2021: +26.5%; 2022: −20.1%; 2023: +15.9%; 2024: +7.9%; 2025: +6.2% +8% 2016 +11% 2017 −9% 2018 +21% 2019 +10% 2020 +27% 2021 −20% 2022 +16% 2023 +8% 2024 +6% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
MMSCX+0.6%+4.9%+6.4%
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full MMSCX performance history →

What MMSCX costs

On a $10,000 investment, MMSCX's 0.94% expense ratio costs about $94 a year. The prospectus estimates $1,619 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full MMSCX fee table →

MMSCX top 10 holdings

#Holding% of fund
1N/a19.15%
2Flex Ltd0.54%
3Credo Technology Group Holding Ltd0.52%
4Revolution Medicines Inc0.49%
5Carpenter Technology Corp0.49%
6Natera Inc0.46%
7Spx Technologies Inc0.45%
8Littelfuse Inc0.44%
9Jabil Inc0.43%
10Franklin Resources Inc0.42%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 23.4% of the fund. See all top 25 holdings and asset mix →

Alternatives to MMSCX

More funds like MMSCX →

MMSCX FAQ

What is the expense ratio of MMSCX?
MMSCX's expense ratio is 0.94%, which works out to about $94 a year for every $10,000 invested. The prospectus estimates total costs of $1,619 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is MMSCX a good investment?
It depends on your goals, but the data points to: broadly diversified (717 holdings); front-end sales load up to 5.25%; 12b-1 marketing fee of 0.25% a year. This is general information, not personalized advice.
What does MMSCX hold?
MMSCX's largest holdings are N/a (19.2%), Flex Ltd (0.5%), Credo Technology Group Holding Ltd (0.5%), Revolution Medicines Inc (0.5%), Carpenter Technology Corp (0.5%). It holds 717 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is MMSCX's 5-year return?
MMSCX returned +4.9% a year over the five years ending Dec 31, 2025, and +6.4% a year over ten years. Past performance does not guarantee future results.
Does MMSCX have a sales load?
Yes. MMSCX has a maximum front-end sales charge of 5.25%.
Who manages MMSCX?
MMSCX is offered by Praxis through Praxis Funds.